MedTrace Logo

Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement

NCT03119038 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-10-27

No results posted yet for this study

Summary

The purpose of this study is to clarify the efficacy of a multidrug versus single drug periarticular injection when only standard operative and postoperative pain management protocols used and the control group is exposed to what our investigators believe is the standard of care, single medication periarticular injection

Conditions

Interventions

DRUG

Bupivicaine + epinephrine

Intraoperative periarticular injection of 30 mL of a 0.25% solution bupivacaine with epinephrine

DRUG

Bupivacaine

Intraoperative periarticular injection of 30 mL of a 0.25% solution bupivacaine without epinephrine

DRUG

Ropivacaine

Intraoperative periarticular injection of 300 mg of 0.5% ropivacaine

DRUG

Ketorolac

Intraoperative periarticular injection of 30 mg

DRUG

Clonidine Injection

Intraoperative periarticular injection of 100 mcg clonidine in a 100 mL 0.9% saline solution

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2022-10-25
Completion
2022-10-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03119038 on ClinicalTrials.gov